We then prepared the N-terminal FITC-labelled versions (90–94, Fig. 8a) and studied their cellular uptake in p53 wild-type HCT-116 colorectal carcinoma cells which were reported to respond to p53 peptides23,81. Here, TP53 is linked to colorectal carcinoma.